Molina Healthcare (MOH)

NYSE Health Care Managed Health Care S&P MidCap 400
$208.99
-7.65 (-3.53%)
Close of Nov 06, 2026 · end-of-day data
Source: Molina Healthcare's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$17.78B$19.88B$18.89B$16.83B$19.42B$27.77B$31.97B$34.07B$40.65B$45.43B
Cost of revenue———$13.90B$15.82B$23.70B$27.18B$28.67B$34.43B$39.49B
Gross profit$1.73B$1.81B$2.52B$2.30B$2.48B$4.07B$4.80B$5.40B$6.22B$5.94B
Operating income$306.00M-$555.00M$1.13B$1.04B$1.08B$1.02B$1.17B$1.57B$1.71B$781.00M
Interest expense$101.00M$118.00M$115.00M$87.00M$102.00M$120.00M$110.00M$109.00M$118.00M$192.00M
Pre-tax income$205.00M-$612.00M$999.00M$972.00M$961.00M$875.00M$1.06B$1.46B$1.59B$589.00M
Income tax$153.00M-$100.00M$292.00M$235.00M$288.00M$216.00M$271.00M$373.00M$410.00M$117.00M
Net income$52.00M-$512.00M$707.00M$737.00M$673.00M$659.00M$792.00M$1.09B$1.18B$472.00M
EBITDA$488.00M-$377.00M$1.26B$1.13B$1.17B$1.15B$1.35B$1.74B$1.89B$976.00M
EPS (basic)$0.93$-9.07$11.57$11.85$11.40$11.40$13.72$18.91$20.52$8.93
EPS (diluted)$0.92$-9.07$10.61$11.47$11.23$11.25$13.55$18.77$20.42$8.92
Diluted shares56.20M56.40M66.60M64.20M59.90M58.60M58.50M58.10M57.70M52.90M
Gross margin9.7%9.1%13.3%13.7%12.8%14.6%15.0%15.9%15.3%13.1%
Operating margin1.7%-2.8%6.0%6.2%5.6%3.7%3.7%4.6%4.2%1.7%
Net margin0.3%-2.6%3.7%4.4%3.5%2.4%2.5%3.2%2.9%1.0%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$2.82B$3.19B$2.83B$2.45B$4.15B$4.44B$4.01B$4.85B$4.66B$4.25B
Short-term investments$1.76B$2.52B$1.68B$1.95B$1.88B$3.20B$3.50B$4.26B$4.33B$4.01B
Receivables$974.00M$871.00M$1.33B$1.41B$1.67B$2.18B$2.30B$3.10B$3.30B$3.53B
Total current assets$5.99B$7.51B$6.46B$5.97B$7.88B$10.06B$10.08B$12.54B$12.77B$12.44B
Goodwill$620.00M$186.00M$143.00M$143.00M$692.00M$982.00M$1.11B$1.24B$1.67B$1.96B
Total assets$7.45B$8.47B$7.15B$6.79B$9.53B$12.21B$12.31B$14.89B$15.63B$15.56B
Total current liabilities$4.57B$5.56B$4.25B$3.27B$4.96B$7.05B$6.86B$8.17B$7.90B$7.37B
Short-term debt$472.00M$653.00M$241.00M$18.00M$0—————
Long-term debt$975.00M$1.32B$1.02B$1.24B$2.13B$2.17B$2.18B$2.18B$2.92B$3.77B
Total debt$1.45B$1.97B$1.26B$1.25B$2.13B$2.17B$2.18B$2.18B$2.92B$3.77B
Total liabilities$5.80B$7.13B$5.51B$4.83B$7.44B$9.58B$9.35B$10.68B$11.13B$11.49B
Shareholders' equity$1.65B$1.34B$1.65B$1.96B$2.10B$2.63B$2.96B$4.21B$4.50B$4.07B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$673.00M$804.00M-$314.00M$434.00M$1.90B$2.12B$773.00M$1.66B$644.00M-$535.00M
Capital expenditures$176.00M$86.00M$30.00M$57.00M$74.00M$77.00M$91.00M$84.00M$100.00M$101.00M
Free cash flow$497.00M$718.00M-$344.00M$377.00M$1.82B$2.04B$682.00M$1.58B$544.00M-$636.00M
Investing cash flow-$206.00M-$1.06B$1.14B-$293.00M-$400.00M-$1.65B-$790.00M-$744.00M-$464.00M$312.00M
Financing cash flow$19.00M$636.00M-$1.19B-$559.00M$217.00M-$183.00M-$441.00M-$58.00M-$347.00M-$170.00M
Share buybacks—$0$0$47.00M$606.00M$128.00M$400.00M$0$1.00B$1.00B
Stock-based compensation$26.00M$46.00M$27.00M$39.00M$57.00M$72.00M$103.00M$115.00M$116.00M$47.00M
Depreciation & amortization$182.00M$178.00M$127.00M$89.00M$88.00M$131.00M$176.00M$171.00M$186.00M$195.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.